chr2-170965948-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015530.5(GORASP2):c.1177G>A(p.Ala393Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A393V) has been classified as Uncertain significance.
Frequency
Consequence
NM_015530.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151910Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251278 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461684Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727132 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151910Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74190 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1177G>A (p.A393T) alteration is located in exon 10 (coding exon 10) of the GORASP2 gene. This alteration results from a G to A substitution at nucleotide position 1177, causing the alanine (A) at amino acid position 393 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at